Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction (Q43704188)

26 November 2017

Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction (English)

1 reference

26 November 2017

O'Brien A

1

1 reference

26 November 2017

Russo-Magno P

2

1 reference

26 November 2017

Karki A

3

1 reference

26 November 2017

Hiranniramol S

4

1 reference

26 November 2017

Hardin M

5

1 reference

26 November 2017

Kaszuba M

6

1 reference

26 November 2017

Sherman C

7

1 reference

26 November 2017

Rounds S

8

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

26 November 2017

1 reference

26 November 2017

164

1 reference

26 November 2017

3

1 reference

26 November 2017

365-371

1 reference

Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflo

26 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Bone turnover during high dose inhaled corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

A measure of quality of life for clinical trials in chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Effect of encouragement on walking test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Suboptimal medical therapy in COPD: exploring the causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.3.2002052

10.1164/AJRCCM.164.3.2002052

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference